Metallothionein overexpression supresses hepatic hyperplasia induced by hepatitis B surface antigen

Toxicology and Applied Pharmacology

Volumn 155, Issue 2, 1999, Pages 107-116

  Quaife, Carol J ^a   Cherne, Russell L ^a   Newcomb, Terry G ^b   Kapur, Raj P ^b   Palmiter, Richard D ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; METALLOTHIONEIN; OXYGEN RADICAL; SCAVENGER; CADMIUM; COPPER; MESSENGER RNA; ZINC;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC ACTIVE HEPATITIS; DNA DAMAGE; HEPATITIS B; HISTOPATHOLOGY; LIVER CELL DAMAGE; LIVER HYPERPLASIA; LIVER PROTECTION; LIVER REGENERATION; LIVER TUMOR; LIVER WEIGHT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCAVENGING SYSTEM; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENETICS; HYPERPLASIA; LIVER; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS; RODENTIA;

ANIMALS; CADMIUM; CADMIUM RADIOISOTOPES; COPPER; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HYPERPLASIA; LIVER; MALE; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RNA, MESSENGER; ZINC;

EID: 0033084196     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8609     Document Type: Article

References (54)

1. Ames B. N., Shigenaga M. K., Hagen T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
2. Bauman J. W., Liu J., Liu Y. P., Klaassen C. D. Increase in metallothionein produced by chemicals that induce oxidative stress. Toxicol. Appl. Pharmacol. 110:1991;347-354.
3. Bergmeyer J. U., Horder M. IFCC methods for alanine aminotransferase. J. Clin. Chem. Clin. Biochem. 18:1980;521-534.
4. Bettger T. M. Zinc and selenium, site-specific versus general anti-oxidation. Can. J. Physiol. Pharmacol. 71:1993;721-724.
5. Bray T. M., Bettger W. J. The physiological role of zinc as an antioxidant. Free Rad. Biol. Med. 8:1993;281-291.
6. Bucher N. L. R. Regeneration of mammalian liver. Int. Rev. Cytol. 15:1963;245-300.
7. Cherian M. G., Howell S. B., Imura N., Klaassen C. D., Koropatnick J., Lazo J. S., Waalkes M. P. Role of metallothionein in carcinogenesis. Toxicol. Appl. Pharmacol. 126:1994;1-5.
8. Chisari F. V., Fillippi P., Buras J., McLachlan A., Popper H., Pinkert C. A., Palmiter R. D., Brinster R. L. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. USA. 84:1987;6909-6913.
9. Chisari F. V., Klopchin K., Moriyama T., Pasquinelli C., Dunsford H. A., Sell S., Pinkert C. A., Brinster R. L., Palmiter R. D. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 59:1989;1145-1156.
10. Chisari F. V., Pinkert C. A., Milich D. R., Filippi P., McLachlan A., Palmiter R. D., Brinster R. L. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science. 230:1985;1157-1160.
11. Chubatsu L. S., Meneghini R. Metallothionein protects DNA from oxidative damage. Biochem. J. 291:1993;193-198.
12. Coppen D. E., Richardson D. E., Cousins R. T. Zinc suppression of free radicals induced in cultures of rat hepatocytes by iron, t-butylhydroperoxide and 3-methylindole. Proc. Soc. Exp. Biol. Med. 189:1988;100-109.
13. Coyle J. T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
14. Dalton T., Palmiter R. D., Andrews G. K. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res. 22:1994;5016-5023.
15. De S. K., McMaster M. T., Andrews G. K. Endotoxin induction of murine metallothionein gene expression. J. Biol. Chem. 265:1990;15267-15274.
16. Dunsford H. A., Sell S., Chisari F. V. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res. 50:1990;3400-3407.
17. Durnam D. M., Palmiter R. D. A practical approach for quantitating specific mRNA by solution hybridization. Anal. Biochem. 131:1983;385-393.
18. Ebadi M., Leuschen M. P., El Refaey H., Hamada F. M., Rojas P. The antioxidant properties of zinc and metallothionein. Neurochem. Int. 29:1995;159-166.
19. Everett R. M., Harrison S. D. Jr. Clinical biochemistry. The Mouse in Biomedical Research. 1983;Academic Press, New York. p. 312-326.
20. Firth C. H., Ward J. M. A morphological classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol. 3:1979;329-351.
21. Hagen T. M., Huang S., Curnette J., Fowler P., Martinez V., Wehr C. M., Ames B. N., Chisari F. V. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 91:1994;12808-12812.
22. Iszard M. B., Liu J., Liu Y., Dalton T., Andrews G. K., Palmiter R. D., Klaassen C. D. Characterization of metallothionein-I-transgenic mice. Toxicol. Appl. Pharmacol. 133:1995;305-312.
23. Jiménez I., Gotteland M., Zarzuelo A., Uauy R., Speisky H. Loss of metal binding properties of metallothionein induced by hydrogen peroxide and free radicals. Toxicology. 120:1997;37-46.
24. Kägi L. H. R. Evolution, structure and chemical activity of class I metallothioneins: An overview. Suzuki K. T., Imura N., Kimura M. Metallothionein III: Biological Roles and Medical Implications. 1993;29-56 Birkhauser Verlag, Berlin.
25. Kondo Y., Kuo L. M., Lazo J. S. Interleukin-1 beta-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum. J. Pharmacol. Exp. Ther. 270:1994;1313-1318.
26. Kondo Y., Woo E. S., Michalska A. E., Choo K. H., Lazo J. S. Metallothionein-null cells have increased sensitivity of anticancer drugs. Cancer Res. 55:1994;2021-2023.
27. Kuo M. T., Zhao J. Y., Teeter L. D., Ikeguchi M., Chisari F. V. Activation of multidrug resistance (P-glycoprotein)mdr3/mdr1a. Cell Growth Diff. 3:1992;531-540.
28. Lazo J. S., Coyle P., Michalska A., Choo K. H., Pitt B. R. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J. Biol. Chem. 270:1995;5506-5510.
29. Ludlow J. W. Interactions between SV 40 large-tumor antigen and the growth suppresser proteins pRB and p53. FASEB J. 7:1993;866-871.
30. Maret W., Vallee B. L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Nat. Acad. Sci. USA. 95:1998;3478-3482.
31. Markant A., Pallauf J. Metallothionein and zinc as potential antioxidants in radical-induced lipid peroxidation in cultured hepatocytes. J. Trace Elements Med. Biol. 10:1996;88-95.
32. Masters B. A., Kelly E. J., Quaife C. J., Brinster R. L., Palmiter R. D. Targeted disruption of metallothionein I and II genes increases sensitivity of cadmium. Proc. Natl. Acad. Sci. USA. 91:1994;584-588.
33. Misra R. R., Hochadel J. F., Smith G. T., Cook J. C., Waalkes M. P., Wink D. A. Evidence that nitric oxide enhances cadmium toxicity by displacing the metal from metallothionein. Chem. Res. Toxicol. 9:1996;326-332.
34. Palmiter R. D., Sandgren E. P., Koeller D. M., Brinster R. L. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol. Cell Biol. 13:1993;5266-5275.
35. Pasquinelli C., Bhavani K., Chisari F. V. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res. 52:1992;2823-2829.
36. Poss K. D., Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA. 94:1997;10925-10930.
37. Quaife C. J., Veith G. C., Palmiter R. D. Transformation of liver by SV 40 T-antigen in transgenic mice is unaffected by metallothionein. Cancer Letts. 106:1996;125-131.
38. Raber M. N., Barlogie B. DNA flow cytometry of human solid tumors. Meaneld M., Lendino F., Mendelsorn M. Flow Cytometry and Sorting. 1990;745-754 Wiley-Liss, New York.
39. Rabinovitch P. S. DNA content histogram and cell cycle analysis. Methods Cell Biol. 41:1994;263-296.
40. Rabinovitch P. S., Reid B. J., Haggitt R. C., Norwood T. H., Rubin C. E. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab. Invest. 60:1989;65-71.
41. Rojas P., Ríos C. Metallothionein inducers protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice. Neurochem. Res. 22:1997;17-22.
42. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radicals Biol. Med. 14:1993;325-327.
43. Sato M., Sasaki M. Enhanced lipid peroxidation is not necessary for induction of metallothionein-I by oxidative stress. Chem. Biol. Interact. 78:1991;143-154.
44. Sato M., Sasaki M., Hojo H. Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6. Arch. Biochem. Biophys. 31:1995;738-744.
45. Schirmacher P., Held W. A., Yang D., Chisari F. V., Rustum Y., Rogler C. E. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res. 52:1992;2549-2556.
46. Shigenaga M. K., Aboujaoude E. N., Chen Q., Ames B. N. Assays of Oxidative DNA Damage Biomarkers 8-Oxo-2′-deoxyguanosine and 8-Oxoquanime in Nuclear DNA and Biological Fluids by High-Performance Liquid Chromatography with Electrochemical Detection. Methods Enzymol. 234:1994;16-33.
47. Suzuki Y., Lyall V., Biber T. U., Ford G. D. A modified technique for the measurement of sulfhydryl groups oxidized by reactive oxygen intermediates. Free Radical Biol. Med. 9:1990;479-484.
48. Thomas J. P., Bachowski G. J., Girotti A. W. Inhibition of cell membrane lipid peroxidation by cadmium and zinc-metallothioneins. Biochim. Biophy. Acta. 884:1986;448-461.
49. Thornalley P. J., Vasak M. Possible role of metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophy. Acta. 827:1985;36-44.
50. Toshkov I., Chisari F. V., Bannasch P. Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology. 20:1994;1162-1172.
51. Udom A. O., Brady F. O. Reactivation in vitro of zinc-requiring apo-enzymes by rat liver zinc-thionein. Biochem. J. 187:1980;329-335.
52. Wisse E., Braet F., Luo D., DeZanger R., Jans D., Crabbé E., Vermoesen A. Structure and function of sinusoidal lining cells in the liver. Toxicol. Pathol. 24:1996;100-111.
53. Woo E., Monks A., Watkins S. C., Wang A., Lazo J. Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel. Cancer Chemother. Pharmacol. 41:1997;61-68.
54. Zheng H., Liu J., Liu Y., Klaassen C. D. Hepatocytes from metallothionein-I and II knockout mice are sensitive to cadmium- andtert. Toxicol. Lett. 87:1996;139-145.